Frontotemporal Disorders Treatment Market is Appraised to be Valued US$ 451.4 Mn, By 2028
With the severe dearth of FDA-approved drugs in the reliable treatment of frontotemporal disorders, frontotemporal disorders treatment continues to underscore the growing significance of disease management. As frontotemporal disorders treatment exclusively includes symptomatic efforts till date, the condition continues to attract research interests worldwide. The available drugs and other means of frontotemporal disorders treatment do not stop or even decelerate the frontotemporal disorders progression, which further remains a key driving force for the growing demand for frontotemporal disorders treatment. Frontotemporal disorders are often misdiagnosed as depression, Parkinson’s, Alzheimer’s, or any other psychiatric condition, thereby limiting the scope of adoption of frontotemporal disorders treatment.
★
★
★
★
★
66 views • 4 slides
